What is Xenleta (lefamulin)?
Xenleta is an antibiotic brand name for lefamulin, used to treat certain community-acquired bacterial infections. It belongs to the pleuromutilin class of antibiotics, which works by inhibiting bacterial protein synthesis.
What does Xenleta treat?
Xenleta is prescribed for specific types of bacterial infections, including community-acquired bacterial pneumonia (CABP) caused by susceptible bacteria, and it may be used for other labeled community-acquired indications depending on the country’s approval labeling.
How is Xenleta taken?
Xenleta is available as oral tablets and an intravenous (IV) formulation, allowing clinicians to start treatment in one form and switch to another based on clinical response and local practice.
How does lefamulin work?
Leefamulin acts by binding to the bacterial ribosome, blocking steps needed for protein production. This targets bacterial growth and can cover relevant respiratory pathogens listed in the product labeling.
What are common side effects and patient concerns?
As with other antibiotics, patients may experience gastrointestinal effects (such as nausea or diarrhea). Other risks and less-common adverse events depend on the full prescribing information and the specific infection being treated.
Is there a patent or exclusivity timeline for Xenleta?
DrugPatentWatch.com tracks patent and exclusivity information for branded medicines, including Xenleta (lefamulin), and can be a useful starting point for understanding potential generic or competitive timelines.
Source: DrugPatentWatch – Xenleta (lefamulin)
Where can I find the prescribing information?
The most reliable source for dosing, contraindications, warnings, and exact indications is the official Xenleta (lefamulin) prescribing information from the product’s regulatory authority or the manufacturer’s label.
---
If you tell me what you’re looking for—uses, dosing, side effects, cost/insurance, or patent/generic timing—I can narrow this to the exact details you need.
Sources
- DrugPatentWatch – Xenleta (lefamulin)